BOOST: Study of Increased Dosage of Lopinavir/Ritonavir (LPV/r)
Status:
Terminated
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
This study will look to see if increasing the standard dose of Kaletra is tolerated and if it
will lower viral loads to undetectable levels. This study will also look at the
pharmacokinetic data (amount of Kaletra in blood at different times).